These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37086925)

  • 1. Dihydrotestosterone-based A-ring-fused pyridines: Microwave-assisted synthesis and biological evaluation in prostate cancer cells compared to structurally related quinolines.
    Kiss MA; Peřina M; Bereczki L; Baji Á; Bělíček J; Jorda R; Frank É
    J Steroid Biochem Mol Biol; 2023 Jul; 231():106315. PubMed ID: 37086925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-ring-fused pyrazoles of dihydrotestosterone targeting prostate cancer cells via the downregulation of the androgen receptor.
    Peřina M; Kiss MA; Mótyán G; Szczyrbová E; Eliáš M; Študent V; Kurfürstová D; Kovalová M; Mada L; Bouchal J; Frank É; Jorda R
    Eur J Med Chem; 2023 Mar; 249():115086. PubMed ID: 36682291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of dihydrotestosterone derivatives modified in the A-ring with (hetero)arylidene, pyrazolo[1,5-a]pyrimidine and triazolo[1,5-a]pyrimidine moieties and their targeting of the androgen receptor in prostate cancer.
    Kiss MA; Peřina M; Bazgier V; May NV; Baji Á; Jorda R; Frank É
    J Steroid Biochem Mol Biol; 2021 Jul; 211():105904. PubMed ID: 33933576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    Jang YG; Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic action of a synthetic androgen ligand mediated by chromatin remodeling in a human prostate cancer cell line.
    Sawada T; Kanemoto Y; Amano R; Hayakawa A; Kurokawa T; Mori J; Kato S
    Biochem Biophys Res Commun; 2022 Jul; 612():110-118. PubMed ID: 35523048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone.
    Chhipa RR; Lee KS; Onate S; Wu Y; Ip C
    Mol Cancer Res; 2009 Sep; 7(9):1543-52. PubMed ID: 19737972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B; Mayer D
    Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.
    Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL
    Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
    Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands.
    Risek B; Bilski P; Rice AB; Schrader WT
    Mol Endocrinol; 2008 Sep; 22(9):2099-115. PubMed ID: 18562628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
    Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
    Kazui Y; Fujii S; Yamada A; Ishigami-Yuasa M; Kagechika H; Tanatani A
    Bioorg Med Chem; 2018 Oct; 26(18):5118-5127. PubMed ID: 30228001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
    Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA
    Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
    Hua Y; Shun TY; Strock CJ; Johnston PA
    Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines.
    Mótyán G; Gopisetty MK; Kiss-Faludy RE; Kulmány Á; Zupkó I; Frank É; Kiricsi M
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors.
    Helsen C; Nguyen TT; Lee XY; Eerlings R; Louros N; Schymkowitz J; Rousseau F; Claessens F; Voet A
    Mol Cancer Ther; 2022 Dec; 21(12):1823-1834. PubMed ID: 36218067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
    Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
    Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydropyrazolo[1,5-a]pyridine-fused steroids and their in vitro biological evaluation in prostate cancer.
    Jorda R; Lopes SMM; Řezníčková E; Ajani H; Pereira AV; Gomes CSB; M V D Pinho E Melo T
    Eur J Med Chem; 2019 Sep; 178():168-176. PubMed ID: 31181481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.